View More Recent Stories
-
Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)
-
iRhythm Technologies (IRTC) Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
-
iRhythm Technologies (IRTC) Tops Q2 EPS by 28c; offers guidance
-
iRhythm Technologies (IRTC) Announces CFO Transition
-
iRhythm Technologies (IRTC) PT Lowered to $120 at Baird
-
Wolfe Research Upgrades iRhythm Technologies (IRTC) to Outperform
-
iRhythm Technologies (IRTC) Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
-
3 MedTech stocks to own for 2024

